50 closest statements
by meaning · ranked by similarity · 100 per pageMeaning search returns the 50 nearest statements, then applies your filters.
“Our mission is to transform the way the world sees the genome through optical genome mapping (“OGM”) solutions, diagnostic services and software.”In use 2026 – now·1 sighting·SEC Form S-1, filed 2026-10-2790% match
“Our mission is to help people access, understand, and benefit from the human genome.”In use 2025 – now·1 sighting·SEC Form 10-K, filed 2025-06-1169% match
“Our mission is to develop products and services based on leading genomics technologies that improve outcomes and enable improved effectiveness, productivity and safety in the research efforts of drug discovery and development companies worldwide.”In use 2003 – now·1 sighting·SEC Form 10-K, filed 2003-03-1968% match
“Our mission is to ‘democratize’ genetic analysis research with products that enable customers to detect and analyze complex genetic diseases by ultra-sensitive screening and monitoring of cell-free genomic targets.”In use 2015 – now·1 sighting·SEC Form S-1/A, filed 2015-03-3168% match
“Our mission is to transform the field of proteomics by broadening access to high-quality proteomic data and to help support fundamental advancements across human health and medicine.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-02-2666% match
“Our mission is to imagine and pioneer new ways to decode the biology of the proteome to improve human health.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-0266% match
“Our mission is to enable the promise of genomics to better human health.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-02-2566% match
“Our mission is to leverage our unique insights into the chromatin regulatory system to pioneer the discovery, development and commercialization of a new class of therapies that transform the lives of patients suffering from a wide spectrum of diseases with high unmet need.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-1166% match
“Our mission is to transform the lives of patients living with devastating genetic diseases by building the leading integrated genetic medicine company focused on developing and commercializing potentially curative therapeutics based on our GeneRide platform.”In use 2021 – now·1 sighting·SEC Form 10-K, filed 2021-03-1566% match
“Our mission is to offer an ecosystem of innovative discovery and translational research solutions that enable our customers to map the universe of biology and conduct scientific exploration that may lead to new therapies to improve the human condition.”In use 2023 – now·1 sighting·SEC Form 10-K, filed 2023-02-2865% match
“Our mission is to enhance disease diagnosis by applying cutting-edge genetic diagnostic technologies, enabling earlier and more accurate detection for timely and improved treatment.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-3165% match
“Our mission is to transform cancer treatment and prevention globally by driving technological innovation and accelerating the adoption of precision oncology medicine.”In use 2020 – now·1 sighting·SEC Form 424B4, filed 2020-06-2265% match
“Our mission is to provide research solutions that facilitate the flow of information from the publishers of scientific, technical, and medical (“STM”) content to enterprise customers in life science and other research intensive organizations around the world.”In use 2014 – now·1 sighting·SEC Form S-1, filed 2014-04-0465% match
“Our mission is to transform cancer care through the smart design and development of targeted solutions based on a deep understanding of cancer pathways and biological markers.”In use 2019 – now·1 sighting·SEC Form 10-K, filed 2019-03-0665% match
“Our mission is to create, develop, manufacture, and deliver cell and gene therapies to transform the lives of people impacted by life-threatening diseases.”In use 2024 – now·1 sighting·SEC Form 10-K, filed 2024-03-1865% match
“Our mission is to translate the promise of gene editing into a broad class of differentiated, transformational medicines for previously untreatable diseases.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-0965% match
“Our mission is to create disease-modifying neurogenetic medicines by identifying validated targets, advancing multiple therapeutic modalities, and delivering them to the right areas within the central nervous system.”In use 2025 – now·1 sighting·SEC Form 10-K, filed 2025-03-1165% match
“Our mission is to become the leading company in precision genetic medicines by discovering, developing, manufacturing, and ultimately commercializing a new class of medicines through our proprietary base editing technology, with the goal of providing life-long cures to patients suffering from serious diseases.”In use 2020 – now·1 sighting·SEC Form 424B4, filed 2020-10-0165% match
“Our mission is to deliver curative, one-time administered genomic medicines that transform the lives of patients.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-0264% match
“Our mission is to enable healthier lives as the premier provider of innovative genetic information with an exceptional customer experience.”In use 2016 – now·1 sighting·SEC Form 10-K, filed 2016-03-0364% match
“Our mission is to create transformative gene-based medicines for serious human diseases.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-02-1264% match
“Our mission is to enable customers across the continuum of molecular research and clinical testing to unlock valuable insights faster, better and more efficiently - from the raw biological sample to the final interpreted results.”In use 2022 – now·1 sighting·SEC Form 20-F, filed 2022-03-1464% match
“Our mission is to lead the convergence of science and light to improve both the environment and human health and wellbeing.”In use 2014 – now·1 sighting·SEC Form 10-K/A, filed 2014-04-1064% match
“Our mission is to deliver transformative therapeutics to those in need, and we believe our innovative EDO technology is well-positioned to effect this change for patients, families and the broader healthcare community.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-0463% match
“Our mission is to develop innovative, transformative therapies for patients with devastating diseases through the use of our novel chRDNA genome-editing technology.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-0563% match
“Our mission is to discover, develop and ultimately deliver medicines that are transformational for patients.”In use 2024 – now·1 sighting·SEC Form 10-K, filed 2024-03-2863% match
“Our mission is to be the foremost biopharma company interrogating ecDNA biology to deliver transformative therapies that improve and extend the lives of patients with previously intractable oncogene amplified cancers.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-0963% match
“Our mission is to bring context to the world of biology and human health through the power of spatial phenotyping.”In use 2025 – now·1 sighting·SEC Form 10-K, filed 2025-03-1763% match
“Our mission is to cure genetic disease, overcome cancer, and feed the planet.”In use 2019 – now·1 sighting·SEC Form S-1/A, filed 2019-03-1363% match
“Our mission is to translate complex, powerful biology with rigor and urgency into life-changing medicines.”In use 2024 – now·1 sighting·SEC Form 10-K, filed 2024-03-1163% match
“Our mission is to Decode Biology to Radically Improve Lives.”In use 2022 – now·1 sighting·SEC Form 10-K, filed 2022-03-2363% match
“Our mission is to become a global leader providing innovative, off-the-shelf and custom-tailored visualization and analysis solutions to organizations across a variety of industries based on highly resistant cameras and supplementary technologies.”In use 2022 – now·1 sighting·SEC Form 10-K, filed 2022-03-3063% match
“Invitae’s mission is to bring comprehensive genetic information into mainstream medical practice to improve the quality of healthcare for billions of people.”In use 2018 – now·1 sighting·SEC Form 10-K, filed 2018-03-0663% match
“Our mission is to develop and manufacture intelligent diagnostic solutions that transform the power of diagnostics into a healthier future for everyone.”In use 2023 – now·1 sighting·SEC Form 10-K, filed 2023-02-2363% match
“Our mission is to be the global leader and pioneer of this new treatment paradigm, integrating recombinant technology, gene therapy and cell therapy to address the challenges of targeting and delivering effective therapies, including to the brain for cancer and other central nervous system (“CNS”) indications.”In use 2026 – now·1 sighting·SEC Form S-1, filed 2026-08-2863% match
“Our mission is to transform lives through innovative medical solutions that improve the health of patients around the world.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-02-1763% match
“Our mission is to leverage unique insights into protein motion to transform the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of small molecule therapies.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-02-2663% match
“Our mission is to accelerate proteomics together.”In use 2021 – now·1 sighting·SEC Form 424B4, filed 2021-07-1663% match
“Our mission is to transform the treatment of serious ophthalmic disease by fully exploiting the Wnt pathway.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-2363% match
“Our mission is to develop transformative, interventional technologies that allow eyecare providers to procedurally elevate the standards of care – empowering people to keep seeing.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-0463% match
“Our mission is to be a leading provider of superior molecular solutions.”In use 2008 – now·1 sighting·SEC Form 10-K, filed 2008-03-0762% match
“Our mission is to accelerate innovation in life sciences and thereby positively impact patient lives globally.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-02-1162% match
“Our mission is to change the global diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis.”In use 2026 – now·1 sighting·SEC Form 20-F, filed 2026-04-0762% match
“Compugen’s mission is to be the world leader in the discovery and licensing of product candidates to the therapeutic and diagnostic industries under milestone and revenue sharing agreements.”In use 2010 – now·1 sighting·SEC Form 20-F, filed 2010-03-1162% match
“Our mission is to transform anemia management in a wide variety of disease states across the globe while improving patients’ lives.”In use 2020 – now·1 sighting·SEC Form 10-K, filed 2020-03-1762% match
“Our mission is to develop life-changing genetic medicines for people and their families impacted by devastating neurological diseases.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-2462% match
“Our mission is to innovate product development that results in a better and healthier world, through our software and hardware infrastructure, and an in-depth knowledge of additive manufacturing.”In use 2026 – now·1 sighting·SEC Form 20-F, filed 2026-04-2362% match
“Our mission is to organize the world’s knowledge in molecular medicine and to make it universally accessible and useful.”In use 2014 – now·1 sighting·SEC Form 10-K, filed 2014-06-0962% match
“Our mission is to transform the lives of patients through the creation of novel gene control medicines by building a fully integrated, leading biopharmaceutical company.”In use 2017 – now·1 sighting·SEC Form 10-K, filed 2017-03-2062% match
“Our mission is to unlock the latent power of proteomics in order to facilitate a more complete understanding of human biology and contribute to the relief of suffering and the extension of healthy, meaningful life.”In use 2021 – now·1 sighting·SEC Form S-1/A, filed 2021-10-0862% match
Showing 1–50 of 50